NewcelX ( ($NCEL) ) has issued an announcement. On December 11, 2025, NewcelX Ltd. announced the publication of a patent application in China for ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

As Big Pharma braces for a massive revenue crash when patents on blockbuster drugs expire, an unexpected player is stepping ...

Dr. Kevin J. Tracey, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research and 2025 fellow of the ...

NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a ...

After a yearslong series of setbacks, NASA's Escape and Plasma Acceleration and Dynamics Explorers, or ESCAPADE, mission has ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

Product liability and real estate practices are well represented, as the Am Law 50 firm returns to electing a typical number of new partners.

Tulane’s J. Quincy Brown named 2025 NAI fellow for pioneering cancer imaging tech, including MAGIC-SCAN system.

"Sticky Kick [s] features tumbled yellow accents on the tongue and heel, the iconic Denny’s logo embossed on the heel counter ...

Shares are up 7% in trading today, after Geron announced a strategic restructuring to "position the company for long-term ...